About the Company
Arcadia Biosciences (Nasdaq: RKDA) is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation. It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Arcadia Biosciences, Inc.
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its ...
Arcadia Biosciences, Inc. Announces Q1 2025 Financial Results ... - Nasdaq
Arcadia Biosciences, Inc. announced that it will release its financial and business results for the first quarter of 2025 on May 8, 2025, and will hold a conference call at 2:00 p.m. Eastern time ...
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full ... - Nasdaq
Arcadia Biosciences, Inc. ®, a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full ...
Arcadia Biosciences, Inc. (RKDA) Q1 2025 Earnings Call Transcript
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2025 Earnings Conference Call May 8, 2025 2:00 PM ETCompany ParticipantsMark Kawakami - Chief Financial ...
Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2024 ...
About Arcadia Biosciences, Inc. Since 2002, Arcadia Biosciences (Nasdaq: RKDA) has been innovating high-value, healthy ingredients to meet consumer demands for healthier choices.
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q2 2024 Earnings Call ...
Arcadia Biosciences, Inc. (NASDAQ: RKDA) Q2 2024 Earnings Call Transcript August 13, 2024 Arcadia Biosciences, Inc. misses on earnings expectations. Reported EPS is $0.78 EPS, expectations were $1.55.
Arcadia Biosciences: Q2 Earnings Snapshot
DALLAS (AP) — DALLAS (AP) — Arcadia Biosciences Inc. (RKDA) on Thursday reported a loss of $4.5 million in its second quarter. On a per-share basis, the Dallas-based company said it had a loss of ...
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2023 ...
About Arcadia Biosciences, Inc. Since 2002, Arcadia Biosciences (Nasdaq: RKDA) has been innovating crops to provide high-value, healthy ingredients to meet consumer demands for healthier choices.
Arcadia Biosciences, Inc.: Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights
DALLAS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the ...
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2025 Earnings Call ...
Operator: Hello, and welcome to Arcadia Biosciences, Inc. First Quarter 2025 Financial Results and Business Highlights Conference Call. At this time, all participants are in a listen-only mode.
Arcadia Biosciences, Inc. (RKDA) Q1 2023 Earnings Call Transcript
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ETCompany ParticipantsT.J.
Similar Companies
Loading the latest forecasts...